Goadsby, Peter J <br/><br/>
A Controlled Trial of Erenumab for Episodic Migraine.  [electronic resource] 

 -  The New England journal of medicine  11 2017 
 - 2123-2132 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa1705848  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Calcitonin Gene-Related Peptide Receptor Antagonists<br/>Chronic Disease<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Injections, Subcutaneous<br/>Least-Squares Analysis<br/>Male<br/>Middle Aged<br/>Migraine Disorders--prevention & control<br/>Young Adult